Foremost amongst these is the deletion or inactivation of the PTEN tumour suppressor gene, an antagonist of the phosphatidylinositol-3-kinase (PI3K/AKT) signaling pathway that promotes cell survival and proliferation. The gene discussed is PTEN; the disease is neoplasm.